A detailed history of Black Rock Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Black Rock Inc. holds 3,292,544 shares of PRCT stock, worth $219 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,292,544
Previous 3,357,638 1.94%
Holding current value
$219 Million
Previous $141 Million 15.63%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$40.38 - $50.75 $2.63 Million - $3.3 Million
-65,094 Reduced 1.94%
3,292,544 $163 Million
Q4 2023

Feb 13, 2024

BUY
$24.89 - $43.41 $10.3 Million - $18 Million
413,629 Added 14.05%
3,357,638 $141 Million
Q3 2023

Nov 13, 2023

BUY
$30.02 - $38.81 $10.9 Million - $14.1 Million
363,883 Added 14.1%
2,944,009 $96.6 Million
Q2 2023

Aug 11, 2023

BUY
$26.7 - $37.02 $18.3 Million - $25.3 Million
684,194 Added 36.09%
2,580,126 $91.2 Million
Q1 2023

May 12, 2023

SELL
$26.64 - $39.74 $141,778 - $211,496
-5,322 Reduced 0.28%
1,895,932 $53.8 Million
Q4 2022

Feb 13, 2023

BUY
$38.78 - $46.78 $3.58 Million - $4.32 Million
92,320 Added 5.1%
1,901,254 $79 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $16.8 Million - $27.6 Million
545,116 Added 43.13%
1,808,934 $75 Million
Q2 2022

Aug 12, 2022

BUY
$29.23 - $44.45 $26.6 Million - $40.5 Million
911,027 Added 258.23%
1,263,818 $41.3 Million
Q1 2022

May 12, 2022

BUY
$16.89 - $35.74 $531,798 - $1.13 Million
31,486 Added 9.8%
352,791 $12.3 Million
Q4 2021

Feb 10, 2022

BUY
$24.6 - $46.29 $7.41 Million - $13.9 Million
301,305 Added 1506.53%
321,305 $8.04 Million
Q3 2021

Nov 09, 2021

BUY
$35.91 - $41.94 $718,199 - $838,800
20,000 New
20,000 $763,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.96B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.